Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Cheung

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Thermal Biology|February 10, 2025
Embryological incubation temperature modulates behaviour in larval white sturgeon (Acispencer transmontanus)Trevor J Hamilton, Katherine Cheung, James Hudson, et al.
Biological Psychiatry|July 26, 2011
Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutationDavid Hessl, John M Wang, Andrea Schneider, et al.
Frontiers in Human Neuroscience|November 2, 2012
Male carriers of the FMR1 premutation show altered hippocampal-prefrontal function during memory encodingJohn M Wang, Kami Koldewyn, Ryu-Ichiro Hashimoto, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|July 31, 2025
Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' ConcernsKatherine Cheung, Maxwell Brodie, Sue-Ling Chang, et al.
Wellcome Open Research|March 26, 2025
Psychedelics as moral bioenhancers: Protocol for a scoping review of ethical arguments for and againstSamuel Streicher, Christopher Register, Xiu Lim, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
D-piece modifications of the hemiasterlin analog HTI-286 produce potent tubulin inhibitorsArie Zask, Gary Birnberg, Katherine Cheung, et al.
European Journal of Medicinal Chemistry|January 16, 2010
The identification of 8,9-dimethoxy-5-(2-aminoalkoxy-pyridin-3-yl)-benzo[c][2,7]naphthyridin-4-ylamines as potent inhibitors of 3-phosphoinositide-dependent kinase-1 (PDK-1)Thomas Nittoli, Russell G Dushin, Charles Ingalls, et al.
The Lancet. Child & Adolescent Health|September 4, 2025
Clinical psychedelic research in adolescents: a scoping review and overview of ethical considerationsKhaleel Rajwani, Edward Jacobs, Lori Bruce, et al.
Palliative Medicine|January 22, 2024
Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based surveyLouis Plourde, Sue-Ling Chang, Houman Farzin, et al.
Journal of Law and the Biosciences|December 15, 2023
Defusing the legal and ethical minefield of epigenetic applications in the military, defense, and security contextGratien Dalpé, Katherine Huerne, Charles Dupras, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Thermal Biology|February 10, 2025
Embryological incubation temperature modulates behaviour in larval white sturgeon (Acispencer transmontanus)Trevor J Hamilton, Katherine Cheung, James Hudson, et al.
Biological Psychiatry|July 26, 2011
Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutationDavid Hessl, John M Wang, Andrea Schneider, et al.
Frontiers in Human Neuroscience|November 2, 2012
Male carriers of the FMR1 premutation show altered hippocampal-prefrontal function during memory encodingJohn M Wang, Kami Koldewyn, Ryu-Ichiro Hashimoto, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|July 31, 2025
Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' ConcernsKatherine Cheung, Maxwell Brodie, Sue-Ling Chang, et al.
Wellcome Open Research|March 26, 2025
Psychedelics as moral bioenhancers: Protocol for a scoping review of ethical arguments for and againstSamuel Streicher, Christopher Register, Xiu Lim, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
D-piece modifications of the hemiasterlin analog HTI-286 produce potent tubulin inhibitorsArie Zask, Gary Birnberg, Katherine Cheung, et al.
European Journal of Medicinal Chemistry|January 16, 2010
The identification of 8,9-dimethoxy-5-(2-aminoalkoxy-pyridin-3-yl)-benzo[c][2,7]naphthyridin-4-ylamines as potent inhibitors of 3-phosphoinositide-dependent kinase-1 (PDK-1)Thomas Nittoli, Russell G Dushin, Charles Ingalls, et al.
The Lancet. Child & Adolescent Health|September 4, 2025
Clinical psychedelic research in adolescents: a scoping review and overview of ethical considerationsKhaleel Rajwani, Edward Jacobs, Lori Bruce, et al.
Palliative Medicine|January 22, 2024
Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based surveyLouis Plourde, Sue-Ling Chang, Houman Farzin, et al.
Journal of Law and the Biosciences|December 15, 2023
Defusing the legal and ethical minefield of epigenetic applications in the military, defense, and security contextGratien Dalpé, Katherine Huerne, Charles Dupras, et al.
Pageof 4